GENE ONLINE|News &
Opinion
Blog

Clinical Trial
Parexel and Japanese Foundation for Cancer Research Collaborate to Boost Oncology Clinical Trials in Japan
2024-01-18
2023 ASCO Annual Meeting: Breakthroughs in Cancer Care and Advances in CAR T-cell Therapy
2023-07-11
Could Bacteria Be Causing Endometriosis?
2023-06-27
Bristol Myers Squibb Releases Promising Preliminary Anemia Clinical Trial Results
2022-10-31
Kura Oncology Boasts Immunotherapy Preliminary Trial Data Success
2022-10-26
Though Alzheimer’s Treatment Fails Presenting Primary Endpoints, TauRx is Still Seeking Approval
2022-10-06
ESMO 2022: Promising Trials Highlights That Are Worth Following
2022-09-21
Pfizer Doses First Patients with an Influenza Vaccine in a Phase 3 Clinical Trial
2022-09-14
Further Clinical Trial Results Reinforce Prior Findings For Astellas’ Menopause Treatment
2022-09-05
Alnylam Posts Positive Phase 2 Results for its RNAi Nephropathy Drug
2022-08-30
Bristol Myers Squibb’s New Drug Boasts Strong Anti-thrombotic Profile
2022-08-29
Vaccine Protecting Against 20 Different Pneumococcal Infections Proves Effective in Trial
2022-08-12
Multiple Myeloma Treatment From BMS Proves Superior Life Expectancy After Further Trial
2022-08-10
Karuna Therapeutics Announces Topline Results from Schizophrenia Therapy Clinical Trial
2022-08-08
LOCOcyte – Avenge Bio’s Potential Treatment for Ovarian Cancer gets FDA Clearance
2022-08-03
1 2 3 14
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top